COMPOSITIONS MONOVALENT FOR CD28 BINDING AND METHODS OF USE
摘要
The present invention provides for a domain antibody (dAb) that binds to CD28 and prevents the binding of CD28 to CD80 and/or CD86, but does not cross-react with CTLA4. Pharmaceutical compositions comprising thereof and uses of the antibody thereof in the preparation of medicaments for the treatment of diseases, including autoimmune diseases or graft-related diseases, are also provided.
申请公布号
AU2015202447(B2)
申请公布日期
2017.01.19
申请号
AU20150202447
申请日期
2015.05.07
申请人
Bristol-Myers Squibb Company;Domantis Limited
发明人
MCKINNON, Murray;NADLER, Steven G.;SUCHARD, Suzanne J.;CLASSON, Brendan;HOLMES, Steve;IGNATOVICH, Olga;PLUMMER, Christopher;GRANT, Steve